Cleared Traditional

K071911 - CARDIOPULMONARY EXERCISE TESTING OPTION...

K071911 is an FDA 510(k) clearance for CARDIOPULMONARY EXERCISE TESTING OPTION..., manufactured by Innovision A/S. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 58-day FDA review.

K071911 · Innovision A/S · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2007
Decision
58d
Days
Class 2
Risk

K071911 is an FDA 510(k) clearance for the CARDIOPULMONARY EXERCISE TESTING OPTION TO INNOCOR. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Innovision A/S (Lake Forest, US). The FDA issued a Cleared decision on September 7, 2007 after a review of 58 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Innovision A/S devices

FDA 510(k) Submission Details - K071911

510(k) Number K071911 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 11, 2007
Decision Date September 07, 2007
Days to Decision 58 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 125d · This submission: 58d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 284
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K071911.
CARTO 3 NAVIGATION SYSTEM (MODEL:FG-5400-00), CARTO 3 EXTERNAL REFERENCE PATCHES (MODEL:D-1283-01)
K072202 · Biosense Webster, Inc. · Nov 2007
MODIFICATION TO: MUSE CARDIOLOGY INFORMATION SYSTEM
K072502 · Ge Medical Systems Information Technologies · Nov 2007
EMS-XL CARDIAC ELECTROPHYSIOLOGY SYSTEM
K071348 · Mennen Medical , Ltd. · Sep 2007
CARTO XP EP NAVIGATION SYSTEM, VERSION 9
K070240 · Biosense Webster, Inc. · May 2007
MODIFICATION TO: ENSITE SYSTEM, MODEL, EE3000
K070902 · St Jude Medical · May 2007
HORIZON SE
K070254 · Mennen Medical , Ltd. · Apr 2007